Results 231 to 240 of about 609,595 (394)

Cervical cancer screening uptake in Côte d'Ivoire: Analysis of prevalence and associated factors. [PDF]

BMC Public Health
Adzigbli LA, Dowou RK, Gbordzoe NI, Mensah T, Arwill G, Aboagye RG, Baiden F.   +6 more
europepmc   +1 more source

Predictors of Screening for Breast, Cervical, Colorectal, and Prostatic Cancer Among Community-Based Primary Care Practices [PDF]

, 2000
Mack T. Ruffin, Daniel W. Gorenflo, B. Woodman   +2 more
openalex   +1 more source

Emerging Nanotechnology Strategies for Obesity Therapy

Advanced Science, EarlyView.
Three types of nanomaterials used for obesity treatment are highlighted, including inorganic nanomaterials, organic nanomaterials and biomimetic nanomaterials. A detailed and comprehensive introduction to the recent nanotechnology strategies for obesity management is also provided, including drug delivery, photodynamic therapy, hyperthermia, gas ...
Weili Chang, Zhaoxu Meng, Yuezhu Zhao, Yake Qi, Zhou Li, He Lian   +5 more
wiley   +1 more source

Patient acceptability of CITOBOT for cervical cancer screening: A mixed-method study. [PDF]

PLoS One
Arrivillaga M, Torres MDM, Neira D, García-Cifuentes JP, Vargas-Cardona HD, Rodríguez-López M, Bermúdez PC.   +6 more
europepmc   +1 more source

ORL@Cu‐MOF Boost Cuproptosis and Suppress Fatty Acid Metabolism for Cancer Lymph Node Metastasis Synergistic Therapy

Advanced Science, EarlyView.
The fabrication of ORL@Cu‐MOF and the mechanism of synergistic therapy by cuproptosis, reprogram fatty acid metabolism and anti‐PD‐1. Abstract Lymph node metastasis (LNM) is one of the significant characteristics of poor prognosis in oral squamous cell carcinoma (OSCC), strongly associated with high mortality rates.
Zi‐Zhan Li, Yi Liu, Kan Zhou, Lei‐Ming Cao, Guang‐Rui Wang, Jinmei Wu, Yi‐Fu Yu, Yao Xiao, Bing Liu, Qiuji Wu, Zhiyong Song, Lin‐Lin Bu   +11 more
wiley   +1 more source

Publication trends and hotspots for cervical cancer screening biomarker: a bibliometric analysis. [PDF]

Discov Oncol
Xu J, Yang W, Liu L, Zhou S, Jin X, Zhao M, Liu M, Meng Y.   +7 more
europepmc   +1 more source

Cervical cancer screening in hospitals: the efficacy of legislation in Maryland.

, 1993
Ann C. Klassen, David D. Celentano, Carol S. Weisman   +2 more
openalex   +2 more sources

Human Papillomavirus DNA Testing for Cervical Cancer Screening in Low-Resource Settings [PDF]

, 2000
Louise Kuhn, L Denny, Amy E. Pollack, A Lörincz, Ralph M. Richart, Thomas C. Wright   +5 more
openalex   +1 more source

Targeting Glutamine Metabolism Transporter SLC25A22 Enhances CD8+ T‐Cell Function and Anti‐PD‐1 Therapy Efficacy in Cervical Squamous Cell Carcinoma: Integrated Metabolomics, Transcriptomics and T‐Cell‐Incorporated Tumor Organoid Studies

Advanced Science, EarlyView.
Through metabolomic and transcriptomic analyses, a glutamine‐enriched, immunosuppressive microenvironment is identified in cervical squamous cell carcinoma (CSCC), highlighting the glutamine transporter SLC25A22 as a key regulator of glutamine metabolism, immune checkpoint activation, and CD8+ T‐cell cytotoxicity.
Tingting Ren, Junjun Qiu, Fanghua Chen, Qian Jiang, Qinqin Liu, Tong Wu, Hua Jiang, Keqin Hua   +7 more
wiley   +1 more source

Barriers of organized cervical cancer screening in Albania and Montenegro. [PDF]

BMC Public Health
Csanádi M, Filipi K, Ylli A, Dedja B, Bejko A, Kovacevic IN, Vukovic-Lekovic J, Stanisic M, Vujovic A, Obeng GD, de Kok IMCM, Vokó Z, Varga O.   +12 more
europepmc   +1 more source